Pharmacy Medical News about Treatment of Myoclonic Astatic Epilepsy

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Current Treatment of Myoclonic Astatic Epilepsy: Clinical Experience at the Children's Hospital of Philadelphia
Epilepsia, 10/05/07

Kilaru, S., et al. - Myoclonic astatic epilepsy (MAE) is a generalized epilepsy of early childhood. Little is known about the use of newer antiepileptic treatments (AET) in MAE. The purpose of this study was to describe the characteristics, treatment, and outcome of a contemporary MAE cohort exposed to the new generation AET...Conclusions: The new generation of AET may offer significant benefit to children with MAE. The KD was the most effective AET in this series, and perhaps should be considered earlier in treatment

<< Previous
Shortened cortical silent period in facial muscles of patients...

Next >>
Changing pattern of candidaemia 2001–2006 and use of antifungal...

Early Myoclonic Encephalopathy and Nonketotic Hyperglycinemia
Pediatric Neurology, 10/20/09 Relevance Score: 87%

The ketogenic diet in treatment of two adults with prolonged nonconvulsive status epilepticus
Epilepsia, 11/05/09 Relevance Score: 82%

Current and future treatment of epilepsy
The Internet Journal of Neurology, 11/03/09 Relevance Score: 82%

Epilepsy in later life
The Lancet Neurology, 10/19/09 Relevance Score: 82%

Visual Field Loss in Patients with Refractory Partial Epilepsy Treated with Vigabatrin: Final Results from an Open-Label, Observational, Multicentre Study
CNS Drugs, 10/28/09 Relevance Score: 81%